HSD17B13 and metabolic dysfunction-associated steatotic liver disease: HSD17B13 has recently been reported as a liver restricted lipid droplet-associated protein whose expression is highly up-regulated in patients with non-alcoholic fatty liver disease although its physiological function remains unclear 71.